Overview Financials News + Filings Key Docs Charts Ownership Insiders |
ARMO BioSciences, Inc. (ARMO)
|
Add to portfolio |
|
|
Price: |
$49.98
| | Metrics |
OS: |
30.4
|
M
| |
|
|
Market cap: |
$1.52
|
B
| |
|
|
Net cash:
|
$165
|
M
| |
$5.44
|
per share
|
EV:
|
$1.35
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 37.0 | 29.2 | 24.7 |
Revenue growth | 26.6% | 18.4% | |
Cost of goods sold | 42.7 | 33.8 | 27.5 |
Gross profit | -5.7 | -4.6 | -2.8 |
Gross margin | -15.5% | -15.6% | -11.5% |
General and administrative | 5.7 | 4.6 | 2.8 |
EBIT | -42.7 | -33.8 | -27.5 |
EBIT margin | -115.5% | -115.6% | -111.5% |
Pre-tax income | 0.0 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 |
Net income | 0.0 | 0.0 | 0.0 |
Net margin | 0.0% | 0.0% | 0.0% |
|
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|